nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—ABCB1—peripheral nervous system neoplasm	0.209	1	CbGaD
Omeprazole—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.0801	0.135	CbGbCtD
Omeprazole—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0403	0.0677	CbGbCtD
Omeprazole—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0388	0.0651	CbGbCtD
Omeprazole—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0376	0.0631	CbGbCtD
Omeprazole—ABCC3—Etoposide—peripheral nervous system neoplasm	0.0369	0.062	CbGbCtD
Omeprazole—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0333	0.0559	CbGbCtD
Omeprazole—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0286	0.0481	CbGbCtD
Omeprazole—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0269	0.0451	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0252	0.0423	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.0218	0.0365	CbGbCtD
Omeprazole—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0192	0.0322	CbGbCtD
Omeprazole—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0165	0.0278	CbGbCtD
Omeprazole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.016	0.0269	CbGbCtD
Omeprazole—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0154	0.0259	CbGbCtD
Omeprazole—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0152	0.0255	CbGbCtD
Omeprazole—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.014	0.0235	CbGbCtD
Omeprazole—ABCB1—Topotecan—peripheral nervous system neoplasm	0.014	0.0235	CbGbCtD
Omeprazole—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0134	0.0225	CbGbCtD
Omeprazole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0128	0.0215	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0103	0.0174	CbGbCtD
Omeprazole—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00969	0.0163	CbGbCtD
Omeprazole—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00837	0.0141	CbGbCtD
Omeprazole—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00808	0.0136	CbGbCtD
Omeprazole—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00779	0.0131	CbGbCtD
Omeprazole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00625	0.0105	CbGbCtD
Omeprazole—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00597	0.01	CbGbCtD
Omeprazole—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00573	0.00963	CbGbCtD
Omeprazole—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00556	0.00935	CbGbCtD
Omeprazole—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00547	0.00918	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00373	0.00626	CbGbCtD
Omeprazole—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00357	0.00601	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00351	0.0059	CbGbCtD
Omeprazole—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00328	0.0055	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00223	0.00375	CbGbCtD
Omeprazole—Pantoprazole—ABCB1—peripheral nervous system neoplasm	0.000514	0.573	CrCbGaD
Omeprazole—Lansoprazole—ABCB1—peripheral nervous system neoplasm	0.000383	0.427	CrCbGaD
Omeprazole—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000331	CcSEcCtD
Omeprazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	6.43e-05	0.00033	CcSEcCtD
Omeprazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	6.41e-05	0.000329	CcSEcCtD
Omeprazole—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000327	CcSEcCtD
Omeprazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	6.36e-05	0.000327	CcSEcCtD
Omeprazole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	6.35e-05	0.000326	CcSEcCtD
Omeprazole—Weight increased—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000326	CcSEcCtD
Omeprazole—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000325	CcSEcCtD
Omeprazole—Weight decreased—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000324	CcSEcCtD
Omeprazole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	6.31e-05	0.000324	CcSEcCtD
Omeprazole—Somnolence—Etoposide—peripheral nervous system neoplasm	6.29e-05	0.000323	CcSEcCtD
Omeprazole—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000323	CcSEcCtD
Omeprazole—Asthenia—Vincristine—peripheral nervous system neoplasm	6.27e-05	0.000322	CcSEcCtD
Omeprazole—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000319	CcSEcCtD
Omeprazole—Infestation—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000319	CcSEcCtD
Omeprazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.21e-05	0.000319	CcSEcCtD
Omeprazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	6.2e-05	0.000318	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000316	CcSEcCtD
Omeprazole—Rash—Dactinomycin—peripheral nervous system neoplasm	6.16e-05	0.000316	CcSEcCtD
Omeprazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	6.15e-05	0.000316	CcSEcCtD
Omeprazole—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000314	CcSEcCtD
Omeprazole—Renal failure—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000314	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	6.11e-05	0.000313	CcSEcCtD
Omeprazole—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	6.1e-05	0.000313	CcSEcCtD
Omeprazole—Fatigue—Etoposide—peripheral nervous system neoplasm	6.1e-05	0.000313	CcSEcCtD
Omeprazole—Stomatitis—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000311	CcSEcCtD
Omeprazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	6.06e-05	0.000311	CcSEcCtD
Omeprazole—Constipation—Etoposide—peripheral nervous system neoplasm	6.05e-05	0.00031	CcSEcCtD
Omeprazole—Pain—Etoposide—peripheral nervous system neoplasm	6.05e-05	0.00031	CcSEcCtD
Omeprazole—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.00031	CcSEcCtD
Omeprazole—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.00031	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.00031	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.00031	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000308	CcSEcCtD
Omeprazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.99e-05	0.000308	CcSEcCtD
Omeprazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.97e-05	0.000307	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000306	CcSEcCtD
Omeprazole—Haematuria—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000304	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000302	CcSEcCtD
Omeprazole—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000302	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000301	CcSEcCtD
Omeprazole—Epistaxis—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000301	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.0003	CcSEcCtD
Omeprazole—Sinusitis—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000299	CcSEcCtD
Omeprazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.83e-05	0.000299	CcSEcCtD
Omeprazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.81e-05	0.000298	CcSEcCtD
Omeprazole—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000298	CcSEcCtD
Omeprazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.78e-05	0.000297	CcSEcCtD
Omeprazole—Dizziness—Vincristine—peripheral nervous system neoplasm	5.77e-05	0.000296	CcSEcCtD
Omeprazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.76e-05	0.000296	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000295	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000295	CcSEcCtD
Omeprazole—Rash—Alitretinoin—peripheral nervous system neoplasm	5.71e-05	0.000293	CcSEcCtD
Omeprazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.71e-05	0.000293	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000293	CcSEcCtD
Omeprazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.69e-05	0.000292	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000292	CcSEcCtD
Omeprazole—Headache—Alitretinoin—peripheral nervous system neoplasm	5.68e-05	0.000291	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.00029	CcSEcCtD
Omeprazole—Urticaria—Etoposide—peripheral nervous system neoplasm	5.62e-05	0.000288	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000288	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000288	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.000287	CcSEcCtD
Omeprazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.59e-05	0.000287	CcSEcCtD
Omeprazole—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.59e-05	0.000287	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000287	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000287	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000286	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	5.55e-05	0.000285	CcSEcCtD
Omeprazole—Vomiting—Vincristine—peripheral nervous system neoplasm	5.55e-05	0.000285	CcSEcCtD
Omeprazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.54e-05	0.000284	CcSEcCtD
Omeprazole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000284	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000283	CcSEcCtD
Omeprazole—Rash—Vincristine—peripheral nervous system neoplasm	5.51e-05	0.000283	CcSEcCtD
Omeprazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.5e-05	0.000282	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000282	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000282	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000282	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000281	CcSEcCtD
Omeprazole—Headache—Vincristine—peripheral nervous system neoplasm	5.47e-05	0.000281	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000279	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000279	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000277	CcSEcCtD
Omeprazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.38e-05	0.000276	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	5.38e-05	0.000276	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000276	CcSEcCtD
Omeprazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.28e-05	0.000271	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000271	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.00027	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000268	CcSEcCtD
Omeprazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.21e-05	0.000268	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000267	CcSEcCtD
Omeprazole—Nausea—Vincristine—peripheral nervous system neoplasm	5.19e-05	0.000266	CcSEcCtD
Omeprazole—Flushing—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000266	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000266	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.16e-05	0.000265	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	5.14e-05	0.000264	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000263	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000262	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000261	CcSEcCtD
Omeprazole—Asthenia—Etoposide—peripheral nervous system neoplasm	5.08e-05	0.000261	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.00026	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.00026	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000259	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000258	CcSEcCtD
Omeprazole—Chills—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000257	CcSEcCtD
Omeprazole—Pruritus—Etoposide—peripheral nervous system neoplasm	5e-05	0.000257	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000255	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000253	CcSEcCtD
Omeprazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.91e-05	0.000252	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000251	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000251	CcSEcCtD
Omeprazole—Rash—Cisplatin—peripheral nervous system neoplasm	4.87e-05	0.00025	CcSEcCtD
Omeprazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.86e-05	0.00025	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000249	CcSEcCtD
Omeprazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.84e-05	0.000248	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000248	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000247	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000246	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000246	CcSEcCtD
Omeprazole—Tension—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000245	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000244	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000242	CcSEcCtD
Omeprazole—Back pain—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000241	CcSEcCtD
Omeprazole—Dizziness—Etoposide—peripheral nervous system neoplasm	4.68e-05	0.00024	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.00024	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000239	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000239	CcSEcCtD
Omeprazole—Chills—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000238	CcSEcCtD
Omeprazole—Nausea—Cisplatin—peripheral nervous system neoplasm	4.59e-05	0.000235	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	4.58e-05	0.000235	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000234	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000232	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000231	CcSEcCtD
Omeprazole—Vomiting—Etoposide—peripheral nervous system neoplasm	4.5e-05	0.000231	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000231	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.00023	CcSEcCtD
Omeprazole—Agitation—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000229	CcSEcCtD
Omeprazole—Rash—Etoposide—peripheral nervous system neoplasm	4.46e-05	0.000229	CcSEcCtD
Omeprazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.46e-05	0.000229	CcSEcCtD
Omeprazole—Headache—Etoposide—peripheral nervous system neoplasm	4.43e-05	0.000227	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000227	CcSEcCtD
Omeprazole—Tension—Doxorubicin—peripheral nervous system neoplasm	4.41e-05	0.000226	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.000226	CcSEcCtD
Omeprazole—Malaise—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.000225	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000224	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000224	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000223	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000223	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000222	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.00022	CcSEcCtD
Omeprazole—Cough—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.000218	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000217	CcSEcCtD
Omeprazole—Nausea—Etoposide—peripheral nervous system neoplasm	4.2e-05	0.000216	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000215	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.17e-05	0.000214	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000213	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000212	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000212	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000212	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000212	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.12e-05	0.000212	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000211	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.00021	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000208	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000208	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000207	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000207	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000205	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000204	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000204	CcSEcCtD
Omeprazole—Infection—Epirubicin—peripheral nervous system neoplasm	3.94e-05	0.000202	CcSEcCtD
Omeprazole—Cough—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000201	CcSEcCtD
Omeprazole—Shock—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.0002	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.0002	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000199	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000199	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000199	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.85e-05	0.000198	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000197	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000196	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000196	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.000196	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	0.000196	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000195	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000194	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000194	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000192	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.00019	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.000188	CcSEcCtD
Omeprazole—Infection—Doxorubicin—peripheral nervous system neoplasm	3.64e-05	0.000187	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000185	CcSEcCtD
Omeprazole—Shock—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000185	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000185	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000184	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000184	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000184	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.56e-05	0.000183	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000183	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000182	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.54e-05	0.000181	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.53e-05	0.000181	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.00018	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000179	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.45e-05	0.000177	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000176	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000175	CcSEcCtD
Omeprazole—Pain—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000174	CcSEcCtD
Omeprazole—Constipation—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000174	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000172	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.00017	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.29e-05	0.000169	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.27e-05	0.000168	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000168	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.000167	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000166	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000166	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.19e-05	0.000164	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000163	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000162	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.15e-05	0.000162	CcSEcCtD
Omeprazole—Pain—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000161	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.14e-05	0.000161	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000161	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000161	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000155	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000154	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.00015	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.00015	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000149	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000149	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.84e-05	0.000146	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.81e-05	0.000144	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000139	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000139	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.63e-05	0.000135	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.62e-05	0.000135	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.6e-05	0.000133	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.52e-05	0.000129	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000129	CcSEcCtD
Omeprazole—Rash—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000128	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000128	CcSEcCtD
Omeprazole—Headache—Epirubicin—peripheral nervous system neoplasm	2.48e-05	0.000128	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.43e-05	0.000125	CcSEcCtD
Omeprazole—Nausea—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000121	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.33e-05	0.00012	CcSEcCtD
Omeprazole—Rash—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000119	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000119	CcSEcCtD
Omeprazole—Headache—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	0.000118	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	0.000112	CcSEcCtD
